{"log_id": 2812280496451874291, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0, "average": 0.988887, "min": 0.988887}, "location": {"width": 27, "top": 69, "height": 26, "left": 1165}, "words": "药"}, {"probability": {"variance": 9e-06, "average": 0.964536, "min": 0.961482}, "location": {"width": 112, "top": 81, "height": 51, "left": 833}, "words": "生药"}, {"probability": {"variance": 0.001393, "average": 0.991129, "min": 0.768892}, "location": {"width": 783, "top": 192, "height": 43, "left": 247}, "words": "现临床恶化(包括出现新的症状)和自杀迹象,特别是在疗程开始的时候或者改变用药剂"}, {"probability": {"variance": 0.001081, "average": 0.986819, "min": 0.888465}, "location": {"width": 199, "top": 244, "height": 30, "left": 248}, "words": "量的时候(增加或减少"}, {"probability": {"variance": 0.00496, "average": 0.985808, "min": 0.558288}, "location": {"width": 741, "top": 273, "height": 41, "left": 289}, "words": "应该告诫患者(和患者的看护人员),注意监测病情恶化(包括出现新的症状)和或出"}, {"probability": {"variance": 0.006212, "average": 0.979169, "min": 0.577559}, "location": {"width": 784, "top": 314, "height": 40, "left": 249}, "words": "现自杀意念/行为或自我伤害念头的情况,旦出现这些症状,要立即寻求医疗建议。应该"}, {"probability": {"variance": 2.8e-05, "average": 0.997559, "min": 0.971091}, "location": {"width": 783, "top": 354, "height": 40, "left": 250}, "words": "意识到一些症状的出现(例如兴奋、静坐不能或躁狂)可能与基础疾病状态或药物治疗有关"}, {"probability": {"variance": 0.001311, "average": 0.988161, "min": 0.823695}, "location": {"width": 444, "top": 398, "height": 36, "left": 259}, "words": "(参见静坐不能、躁狂和双相情感障碍:不良反应)"}, {"probability": {"variance": 0.003296, "average": 0.981776, "min": 0.690478}, "location": {"width": 743, "top": 431, "height": 41, "left": 290}, "words": "如果患者出现临床恶化(包括出现新的症状),和或出现自杀意念/行为,特别是那些"}, {"probability": {"variance": 6.7e-05, "average": 0.997541, "min": 0.953943}, "location": {"width": 672, "top": 473, "height": 37, "left": 252}, "words": "严重、突然发生或新出现的症状,应该考虑变更治疗方案,包括可能停用药物"}, {"probability": {"variance": 0.000474, "average": 0.993951, "min": 0.865606}, "location": {"width": 743, "top": 509, "height": 40, "left": 292}, "words": "所有接受抗抑郁药物治疗的患者都应当接受适当的监测,严密观察是否出现了病情恶"}, {"probability": {"variance": 5e-06, "average": 0.998184, "min": 0.988055}, "location": {"width": 783, "top": 548, "height": 41, "left": 252}, "words": "化、自杀倾向和行为异常变化,特别是在疗程开始的最初几个月内,或者是在改变用药剂"}, {"probability": {"variance": 1.2e-05, "average": 0.997455, "min": 0.987165}, "location": {"width": 251, "top": 597, "height": 30, "left": 255}, "words": "量的时候(增加或减少剂量"}, {"probability": {"variance": 0.001038, "average": 0.993418, "min": 0.800873}, "location": {"width": 740, "top": 626, "height": 40, "left": 294}, "words": "在因重度抑郁症以及其他适应症而接受抗抑郁药物治疗的成人和儿童患者中,不论是"}, {"probability": {"variance": 3.2e-05, "average": 0.997514, "min": 0.964918}, "location": {"width": 760, "top": 665, "height": 41, "left": 255}, "words": "否属于精神疾病,受试者都曾报告出现过以下症状:焦虑、激越、惊恐发作、失眠、易怒"}, {"probability": {"variance": 0.000719, "average": 0.989067, "min": 0.862352}, "location": {"width": 782, "top": 704, "height": 41, "left": 255}, "words": "敌意、攻击性、冲动、静坐不能(静坐困难)、轻度躁狂、躁狂症。尽管这些症状与临床上"}, {"probability": {"variance": 0.00369, "average": 0.982744, "min": 0.658883}, "location": {"width": 778, "top": 742, "height": 42, "left": 256}, "words": "抑郁症的病情恶化和/或自杀风险的因果关系尚未得到证实,但是这些症状可能会是自杀行"}, {"probability": {"variance": 2e-06, "average": 0.998323, "min": 0.996966}, "location": {"width": 83, "top": 796, "height": 24, "left": 257}, "words": "为的前兆"}, {"probability": {"variance": 0.001623, "average": 0.989631, "min": 0.75426}, "location": {"width": 724, "top": 820, "height": 41, "left": 298}, "words": "如果患者的抑郁症病情持续恶化、出现自杀意念/行为、出现抑郁加重征象或自杀先"}, {"probability": {"variance": 1e-06, "average": 0.999087, "min": 0.99588}, "location": {"width": 766, "top": 859, "height": 41, "left": 258}, "words": "兆,特别是这些症状属于重度、突发或新出现的时候,应该考虑变更治疗方案,包括可"}, {"probability": {"variance": 5e-06, "average": 0.998664, "min": 0.99365}, "location": {"width": 125, "top": 912, "height": 28, "left": 257}, "words": "能需停止用药"}, {"probability": {"variance": 2.3e-05, "average": 0.997788, "min": 0.973386}, "location": {"width": 725, "top": 937, "height": 41, "left": 300}, "words": "如果决定停止治疗,由于本品有停药风险,应在尽可能快速的情况下逐渐减量,要注"}, {"probability": {"variance": 0.000181, "average": 0.99329, "min": 0.945084}, "location": {"width": 554, "top": 981, "height": 37, "left": 262}, "words": "意突然停药会出现某些症状(参见【注意事项】和【用法用量】"}, {"probability": {"variance": 0.000125, "average": 0.996471, "min": 0.931953}, "location": {"width": 739, "top": 1014, "height": 42, "left": 302}, "words": "在因重度抑郁症或其他适应症(不论是否属于精神疾病)接受抗抑郁药物治疗的过程"}, {"probability": {"variance": 1.5e-05, "average": 0.997856, "min": 0.982423}, "location": {"width": 780, "top": 1052, "height": 42, "left": 263}, "words": "中,要告诫家属或护理人员,应当密切监测患者的兴奋、易怒、行为异常变化或上述的其"}, {"probability": {"variance": 6.7e-05, "average": 0.996953, "min": 0.951728}, "location": {"width": 779, "top": 1090, "height": 44, "left": 264}, "words": "他症状,以及自杀倾向等,要及时地将这些症状报告给医务人员或医疗机构。家属或护理"}, {"probability": {"variance": 3e-06, "average": 0.998589, "min": 0.993026}, "location": {"width": 241, "top": 1141, "height": 32, "left": 264}, "words": "人员每天都要进行病情监测"}, {"probability": {"variance": 0.005969, "average": 0.962809, "min": 0.74388}, "location": {"width": 172, "top": 1181, "height": 25, "left": 306}, "words": "2、5-羟色胺综合征"}, {"probability": {"variance": 0.011737, "average": 0.92305, "min": 0.638799}, "location": {"width": 179, "top": 1223, "height": 23, "left": 306}, "words": "已有单用 SNRIS和SSF"}, {"probability": {"variance": 0.010679, "average": 0.971804, "min": 0.454684}, "location": {"width": 519, "top": 1209, "height": 35, "left": 527}, "words": "发生可能威胁生命的5-羟色胺综合征的报告,包括本品,特"}, {"probability": {"variance": 0.007328, "average": 0.969337, "min": 0.595265}, "location": {"width": 760, "top": 1247, "height": 42, "left": 266}, "words": "别是与其他5-羟色按能药(包括曲坦类药、三环抗抑郁药、芬太尼、锂、曲马多、色氨酸"}, {"probability": {"variance": 0.008343, "average": 0.97333, "min": 0.52482}, "location": {"width": 778, "top": 1285, "height": 42, "left": 269}, "words": "丁螺环酮和圣约翰草)合用,。也有用减少5-羟色胺代谢的药物发生5-羟色胺综合征的报告"}, {"probability": {"variance": 0.001779, "average": 0.984728, "min": 0.809189}, "location": {"width": 732, "top": 1324, "height": 42, "left": 287}, "words": "特别是 MAOIS,包括拟用于治疗精神病和其他疾病,例如利奈唑胺或静脉注射亚甲蓝)"}, {"probability": {"variance": 0.003068, "average": 0.980159, "min": 0.743276}, "location": {"width": 718, "top": 1364, "height": 39, "left": 330}, "words": "羟色胺综合征的症状可包括精神状态的变化(例如,激越、幻觉、谵妄和昏迷)、自"}, {"probability": {"variance": 0.000617, "average": 0.992022, "min": 0.846265}, "location": {"width": 780, "top": 1402, "height": 43, "left": 270}, "words": "主神经不稳定(例如,心动过速、血压不稳定、头晕、多汗、面红、高热)、神经肌肉症状"}, {"probability": {"variance": 0.000146, "average": 0.993296, "min": 0.94594}, "location": {"width": 748, "top": 1443, "height": 41, "left": 281}, "words": "(例如,震颤、强直、肌阵挛、反射亢进、共济失调)、癫痫发作和/或胃肠道症状(例如"}, {"probability": {"variance": 0.011602, "average": 0.955854, "min": 0.506242}, "location": {"width": 506, "top": 1486, "height": 37, "left": 272}, "words": "恶心、呕吐、腹泻)。应注意监测患者出现5一羟色胺综合征"}], "language": 3}